We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDDDD.L Regulatory News (DDDD)

  • There is currently no data for DDDD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Second Price Monitoring Extn

12 Dec 2018 16:40

RNS Number : 3084K
4d Pharma PLC
12 December 2018
 

Second Price Monitoring Extension

A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes.

Following the first price monitoring extension this security would still have executed more than a pre-determined percentage above or below the price of the most recent automated execution today. London Stock Exchange electronic order book users have a final opportunity to review the prices and sizes of orders entered in this security prior to the auction execution.

The applicable percentage is set by reference to a security's Millennium Exchange sector. This is set out in the Sector Breakdown tab of the Parameters document at www.londonstockexchange.com/tradingservices

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
APMUUSNRWRAUAAA
Date   Source Headline
2nd Aug 20217:00 amRNSTwo MRx0518 presentations accepted for ESMO 2021
29th Jul 20217:00 amRNS$30 Million Credit Facility with Oxford Finance
26th Jul 20211:00 pmRNSPassing of Chief Financial Officer John Beck
6th Jul 20217:00 amRNSPublication - LBP improves activity of CAR-T
29th Jun 20217:00 amRNSLadenburg Thalmann Healthcare Conference
22nd Jun 20217:00 amRNSConference presentation on LBP Manufacturing’
4th Jun 20217:00 amRNSAsthma trial Part A enrolment and program update
1st Jun 20218:52 amRNSTotal Voting Rights
24th May 202110:48 amRNSResult of AGM
24th May 20217:00 amRNSUpdate on Data for Phase II Study of Blautix
17th May 20217:00 amRNSPresentation of Blautix IBS Phase II at DDW 2021
19th Apr 20217:00 amRNSCollaboration with Parkinson’s UK
16th Apr 20217:00 amRNSDirectors’ Subscription for new Ordinary Shares
15th Apr 20215:00 pmRNSAnnual Financial Report
15th Apr 20217:00 amRNSParticipation in Jefferies Therapeutics Summit
12th Apr 20212:26 pmRNSHolding(s) in Company
7th Apr 20217:00 amRNSHow to Convert AIM Ordinary Shares into Nasdaq ADS
1st Apr 20217:00 amRNSFinal Results
26th Mar 20213:21 pmRNSHolding(s) in Company
25th Mar 202112:08 pmRNSHolding(s) in Company
25th Mar 20218:00 amRNSHolding(s) in Company
22nd Mar 20217:00 amRNSCompletion of Merger
18th Mar 20211:25 pmRNSResult of Meeting
17th Mar 20211:00 pmRNS4D Pharma Announces Private Placement
3rd Mar 20217:00 amRNSInvestor conference participation
1st Mar 20215:49 pmRNSExercise of Options and Total Voting Rights
1st Mar 20217:02 amRNSJohn Beck Appointed as Chief Financial Officer
1st Mar 20217:00 amRNSAppoints Paul Maier to the Board as NED
26th Feb 202112:52 pmRNSHolding(s) in Company
26th Feb 20217:02 amRNSPosting of Circular
26th Feb 20217:00 amRNSU.S. SEC Declares Registration Statement Effective
16th Feb 20217:00 amRNSMicrobiome Leaders Panel Event
8th Feb 20217:45 amRNSHolding(s) in Company
8th Feb 20217:00 amRNSOncology Clinical Collaboration
4th Feb 20212:55 pmRNSHolding(s) in Company
3rd Feb 20217:00 amRNSOncology Program Update
1st Feb 20212:10 pmRNSTotal Voting Rights
27th Jan 20217:00 amRNSHolding(s) in Company
25th Jan 20216:01 pmRNSHolding(s) in Company
21st Jan 20217:00 amRNSConference participation
30th Dec 20208:32 amRNSHolding(s) in Company
29th Dec 20205:17 pmRNSHolding(s) in Company
29th Dec 20202:24 pmRNSHolding(s) in Company
22nd Dec 20202:31 pmRNSHolding(s) in Company
18th Dec 20208:53 amRNSJoins MJFF-sponsored Parkinson’s study consortium
27th Nov 20203:42 pmRNSHolding(s) in Company
26th Nov 20207:09 amRNSRegistration Statement filed with SEC
23rd Nov 20207:00 amRNSLongevity extends Business Combination deadline
12th Nov 202012:18 pmRNSHolding(s) in Company
9th Nov 20206:21 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.